Guidelines: ESMO Guidelines Compilation (European Union): Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::European Society for Medical Oncology]]. | '''Sponsor, manager or home institution:''' [[dataOwner::European Society for Medical Oncology]]. | ||
'''Available guidelines:''' [[hasClinicalGuidelines::Available Guidelines: ESMO Guidelines]]. | '''Available guidelines:''' [[hasClinicalGuidelines::Available Guidelines: ESMO Guidelines]] [https://www.esmo.org/guidelines/guidelines-by-topic]. | ||
'''Type of information:''' Guidelines for each step in the cancer journey including information on incidence and epidemiology; diagnosis, pathology and molecular biology; staging and risk assessment; management of advanced and metastatic disease; personalised medicine; long-term implications and survivorship; among other information specific to each cancer type. All guidelines have references and methodology sections. | '''Type of information:''' Guidelines for each step in the cancer journey including information on incidence and epidemiology; diagnosis, pathology and molecular biology; staging and risk assessment; management of advanced and metastatic disease; personalised medicine; long-term implications and survivorship; among other information specific to each cancer type. All guidelines have references and methodology sections. | ||
'''Access to information:''' List of guidelines [https://www.esmo.org/guidelines/guidelines-by-topic]. | '''Access to information:''' List of guidelines [https://www.esmo.org/guidelines/guidelines-by-topic]. | ||
Revision as of 17:28, 25 April 2024
Go back to European Union page
Primary purpose: Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available.
Sponsor, manager or home institution: European Society for Medical Oncology.
Available guidelines: Available Guidelines: ESMO Guidelines [1].
Type of information: Guidelines for each step in the cancer journey including information on incidence and epidemiology; diagnosis, pathology and molecular biology; staging and risk assessment; management of advanced and metastatic disease; personalised medicine; long-term implications and survivorship; among other information specific to each cancer type. All guidelines have references and methodology sections.
Access to information: List of guidelines [2].
